|
Week - 1
|
Upstream Process |
|
Week - 2
|
Cell Banks |
|
Week - 3
|
Master Cell Bank (MCB) |
|
Week - 4
|
Working Cell Bank (WCB) |
|
Week - 5
|
End of Production Cells (EOPC) |
|
Week - 6
|
Viability, Stability, Purity of Cell Banks |
|
Week - 7
|
Scale-up for Commercial Product Development |
|
Week - 8
|
Large Scale Fermentation Processes |
|
Week - 9
|
Fermentors and Bioreactors |
|
Week - 10
|
Downstream Process |
|
Week - 11
|
İnitial Product Recovery, Cell Disruption and Removal of Nucleic Acids
|
|
Week - 12
|
Initial Product Concentration |
|
Week - 13
|
Analytical Characterization of Therapeutic Protein |
|
Week - 14
|
Purification of Recombinant Therapeutic Protein |
Anadolu Info Package 
Turkish 
English